LIVER CANCER: HEPATOCELLULAR CARCINOMAantiviral medicationschronic hepatic inflammationHepatitis B virus infectionhepatocellular carcinomaradiologyvaccination strategiesHepatocellular carcinoma (HCC or hepatoma) is the most common primary liver malignancy. Chronic hepatic inflammation is the major driving factor in ...
该试验使用与TACTICS试验相同的纳入和排除标准以及相同的TACE特异性PFS终点来检查LEN+TACE的获益，其相关结果近期于Liver Cancer杂志发表，肝癌在线特此报道。研 究 方 法 研究纳入先前未接受全身治疗、肝动脉灌注化疗或免疫治疗，且不符合肝切除或经皮消融治疗的HCC患者。LEN在第一次TACE前14-21天给药，TACE前2天停...
et al Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res. 2007 Jan;13(2 Pt 1):427–33.
is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known asliver metastasis(肝转移), is more common than that which starts in the liver. Symptoms of liver cancer may include alump (肿块)or pain in the right side below...
原发性肝癌(primary liver cancer, PLC)有三种主要的组织学亚型-肝细胞癌(hepatocellular carcinoma, HCC),肝内胆管癌(intrahepatic cholangiocarcinoma, ICC)和肝细胞和肝内胆管癌合并(combined hepatocellular and intrahepatic cholangiocarcinoma, CHC)。尽管免疫治疗最近取得了进展,但我们对PLC的肿瘤免疫微环境基线情况的...
Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma The molecular landscape of Fibrolamellar Hepatocellular Carcinoma (FLC), a rare liver cancer, remains to be characterised. Here, multi-omics analysis of liver tumours across differen...
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. HCC is the fourth most common cause of cancer death in the world with 610,000 deaths per year compared with 519,000 deaths per year for breast cancer (the fifth most common cause). In the United States ...
Liver cancer, or hepatic cancer, is a malignant tumour that grows on the surface or inside the liver. The leading cause is a viral infection with hepatitis B or C virus. The most frequent liver cancers are hepatocellular carcinoma and hepatoblastoma (formed by immature liver cells). ...
原始出处: Ya-Wen Hung, I-Cheng Lee, Chen-Ta Chi, et al. Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria. Liver Cancer. DOI: 10.1159/000517393. Published online: July 22, 2021....
近日,来自日本信州大学医学院Naoki Tanaka教授团队的研究人员近期在《Liver Cancer》杂志发文:Jia F, Diao P, Wang X, Hu X, Kimura T, Nakamuta M, Nakamura I, Shirotori S, Sato Y, Moriya K, Koike K, Gonzalez FJ, Nakayama J, A...